Skip to content
MS
unreviewed

LCAT

0 reactions · 0 pathways

What it does, reaction by reaction

0 reactions

This enzyme appears only in the regulation table, with no catalysed step recorded.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Lipoprotein Metabolism (Exogenous and Endogenous Pathways: chylomicrons, VLDL, LDL, HDL)

Accelerated by

ApoA-I; HDL substrate availability

Inhibited by

Severe apoA-I deficiency or LCAT deficiency

Hormonal control

No dominant acute hormonal control; governed by HDL/apoA-I availability

Recent literature

Europe PMC · from cache · sorted by publication date

  1. 1
  2. 2
    Multi-omics dissection of metabolic hijacking: Infectious bronchitis virus orchestrates lipid-centric replication through PPAR-TGF-β crosstalk.

    Yan K, Wang X, Bo Z, Zhang C, Guo M, Zhang X, Wu Y. · 2026-01-28

    cited 1× open access unreviewed
  3. 3
  4. 4
    Clinical applications of artificial intelligence-driven nitric oxide: a bibliometric and scientific mapping analysis.

    Liu Z, Abulaiti A, Zhao Y, Zang J, Li G, Shu L, Wahafu P, Yakufu M. · 2026-01-06

    open access unreviewed
  5. 5
    Psychological stress-associated ceramide and diacylglyceride lipotoxicity as contributors to first-episode depression pathophysiology: A neuroimmune-metabolic-oxidative stress (NIMETOX) perspective.

    Sirivatanapa V, Janta P, Almulla AF, Vasupanrajit A, Tunvirachaisakul C, Sriswasdi S, Tansawat R, Carvalho AF… · 2026-08-06

    unreviewed
  6. 6
  7. 7
    Targeting ADAR1-mediated RNA editing inhibits hepatic stellate cell activation and liver fibrosis by enhancing HSC-intrinsic innate immunity.

    Xi Y, Liu L, Kim JW, Zhang M, Wang X, Abdirassil A, Xu M, Ren S, Wang Q, Yang D, Xu P, Xie W. · 2026-08-06

    unreviewed
  8. 8
    Randomized Controlled Trial of Upper Esophageal Sphincter Assist Device in Laryngopharyngeal Reflux Disease.

    Yadlapati R, Robles L, Clarke MK, Low EE, Walsh E, Krause AJ, Kaizer A. · 2025-12-22

    cited 1× open access unreviewed
  9. 9
    Extraction and UPLC-MS-MS identification of active ingredients of Henophyton deserti: Antibacterial, antifungal and in silico studies.

    Boukhalfa O, Sekkoum K, Rabia SH, Belboukhari N, Locatelli M, Malik A, Said MA, Ali I. · 2026-07-21

    unreviewed
  10. 10
    Effect of the hepatokine Tsukushi on HDL and reverse cholesterol transport.

    Lam S, Wong Y, Wing-Ming Shiu S, Lee CH, Choon-Beng Tan K. · 2026-07-20

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.